Using imaging technologies in Drug Development
Pharmaco-imaging is the key to understanding the action of a new drug on the diseases studied. Thanks to Oncodesign Services advanced technologies such as MRI, SPECT/CT, PET/MR, CT, or Optical Imaging, you can explore the body on a micro and macroscopic scale and obtain valuable translational data.
Key benefits of imaging tools in Drug Development
Constantly evolving, preclinical imaging is transforming medicine and Drug Discovery. As a specialized CRO, we are convinced of the contribution of imaging to your preclinical programs:
- Non-invasive and serial tumor monitoring
- Decrease the number of animals used
- Characterization of drug mechanism of action
- Early and predictive evaluation of drug potency
This helps accelerate the drug discovery process, , and optimize treatment protocols more quickly.
Example of modalities in imaging platform
- Magnetic Resonance Imaging (MRI)
- Nuclear imaging (PET/CT, SPECT/CT, PET/MR)
- Optical imaging (Bioluminescence, Fluorescence)
- Ultrasound
Oncodesign Services imaging platform to support your drug development
Oncodesign Services provides imaging services throughout the drug development process for:
- Target Validation
- Pharmacokinetics
- Toxicity
- Efficacy
- Identifying Translational Biomarkers
Oncodesign Services’ in vivo multi-modal imaging platform can be used for biodistribution studies, tumor tracking and to detect biomarkers of activity.
DRIVE-MRT: a premium “nuclear medicine” solution in Oncology
DRIVE-MRT is part of our continuous improvement in the integrated drug discovery support. Oncodesign Services and its strategic partners Covalab, CheMatech, and ABX-CRO are applying their expertise in the rationalization, design, and optimization of targeted radiopharmaceutical agents.